Intarcia Therapeutics Company

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.


Connections from

Estimated Revenue: $10M to $50M
Headquarters: United States
Founded Date: 1997
Technology: Immunotherapy
Industry: Genomic and Epigenominc Instabillity
Employee Number: 251-500